BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23152557)

  • 1. Type-specific detection of 30 oncogenic human papillomaviruses by genotyping both E6 and L1 genes.
    Peng J; Gao L; Guo J; Wang T; Wang L; Yao Q; Zhu H; Jin Q
    J Clin Microbiol; 2013 Feb; 51(2):402-8. PubMed ID: 23152557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue.
    Zou R; Xie W; Wang H; Wang J; Xiao L; Ji S; Chen X; Zhang L; Xue X; Chen J
    Clin Lab; 2016; 62(6):1075-85. PubMed ID: 27468570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.
    Basu P; Chandna P; Bamezai RN; Siddiqi M; Saranath D; Lear A; Ratnam S
    J Clin Microbiol; 2011 Oct; 49(10):3537-44. PubMed ID: 21813716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uniplex E6/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types.
    Okodo M; Okayama K; Teruya K; Sasagawa T
    J Med Virol; 2018 May; 90(5):981-988. PubMed ID: 29314149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV).
    Sasagawa T; Minemoto Y; Basha W; Yamazaki H; Nakamura M; Yoshimoto H; Sakaike J; Inoue M
    Virus Res; 2000 Apr; 67(2):127-39. PubMed ID: 10867192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay.
    Liu SS; Leung RC; Chan KK; Cheung AN; Ngan HY
    J Clin Microbiol; 2010 Mar; 48(3):758-64. PubMed ID: 20042614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
    Pasquier C; Raymond S; Carcenac R; Demmou S; Ranger N; Nicot F; Izopet J
    J Med Virol; 2024 May; 96(5):e29652. PubMed ID: 38727029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new PCR-based mass spectrometry system for high-risk HPV, part I: methods.
    Yi X; Li J; Yu S; Zhang A; Xu J; Yi J; Zou J; Nie X; Huang J; Wang J
    Am J Clin Pathol; 2011 Dec; 136(6):913-9. PubMed ID: 22095377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
    Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
    Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
    Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
    J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
    Ardiç N; Oztürk O; Ergünay K; Sezer O
    Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
    Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
    Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotyping and Phylogenetic Analysis of Human Papillomaviruses in Formalin Fixed Paraffin Embedded Sections from Cervical Lesions in Duhok-Iraq.
    Othman AA; Goreal AA; Pity IS
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1313-1319. PubMed ID: 37116154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-specific detection of human papillomaviruses in Kazakh esophageal squamous cell carcinoma by genotyping both E6 and L1 genes with MALDI-TOF mass spectrometry.
    Dong HC; Cui XB; Wang LH; Li M; Shen YY; Zhu JB; Li CF; Hu JM; Li SG; Yang L; Zhang WJ; Chen YZ; Li F
    Int J Clin Exp Pathol; 2015; 8(10):13156-65. PubMed ID: 26722514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human papilloma virus genotyping assay using restriction fragment mass polymorphism analysis, and its comparison with sequencing and hybrid capture assays].
    Lee EH; Chung HJ; Oh HB; Chi HS; Jee MS; Park SN; Hong SP; Yoo W; Kim SO
    Korean J Lab Med; 2007 Feb; 27(1):62-8. PubMed ID: 18094553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.
    Yamada T; Manos MM; Peto J; Greer CE; Munoz N; Bosch FX; Wheeler CM
    J Virol; 1997 Mar; 71(3):2463-72. PubMed ID: 9032384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
    Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
    J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
    Hariri S; Steinau M; Rinas A; Gargano JW; Ludema C; Unger ER; Carter AL; Grant KL; Bamberg M; McDermott JE; Markowitz LE; Brewer NT; Smith JS
    PLoS One; 2012; 7(3):e34044. PubMed ID: 22479516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.